4//SEC Filing
Liang Howard 4
Accession 0001651308-21-000109
CIK 0001651308other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:48 PM ET
Size
6.3 KB
Accession
0001651308-21-000109
Insider Transaction Report
Form 4
BeiGene, Ltd.BGNE
Liang Howard
CFO & Chief Strategy Officer
Transactions
- Sale
American Depositary Shares
2021-06-07$354.16/sh−650$230,203→ 0 total
Holdings
- 1,565,265
Ordinary Shares
Footnotes (3)
- [F1]Each American Depositary Share represents 13 Ordinary Shares.
- [F2]The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service. Unvested securities are subject to accelerated vesting upon a sale event.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.65 to $354.25, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
Documents
Issuer
BeiGene, Ltd.
CIK 0001651308
Entity typeother
Related Parties
1- filerCIK 0001663427
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 4:48 PM ET
- Size
- 6.3 KB